Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
TNXP
$5.17
+0.78%
TNXP
· Tonix Pharmaceuticals Holding Corp.
$5.17
+0.04 (+0.78%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$88.67M
Shares
17.15M
Volume · Oct 23
754.75K
Avg daily vol (3M)
638.76K
All webcasts
Earnings call · FY2025 Q4
Tonix Pharmaceuticals Holding Corp. (TNXP) Q4 2025 Earnings Call
Revenue · derived Q4
$5.39M
+108.8% YoY
Gross margin · derived Q4
80.4%
+26.2 pp YoY
Net income · derived Q4
-$46.91M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 13, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 12, 2026 · complete as-filed document